ICG-99mTc-纳胶体在宫颈癌前哨淋巴结检测中的作用:一项先导研究
这项前瞻性先导研究纳入16例宫颈癌患者,术前19-21小时注射ICG-99mTc-纳胶体行平面和SPECT/CT淋巴显像,其中14例加用蓝染剂。共切除69枚前哨淋巴结,放射性信号检出66枚、荧光信号检出67枚,蓝染剂仅在14例中的12例(85.7%)检出35枚。作者结论为ICG-99mTc-纳胶体前哨淋巴结活检在早期宫颈癌中可行且安全,检出率高于蓝染剂,可能成为联合技术的替代方案。
要点
- 16例宫颈癌患者术前19-21小时注射ICG-99mTc-纳胶体,平面和SPECT/CT淋巴显像均显示引流。
- 共切除69枚前哨淋巴结,放射性信号检出66枚,荧光信号检出67枚。
- 蓝染剂在14例中的12例(85.7%)仅检出35枚前哨淋巴结,检出率低于杂合示踪剂。
核心结论
- 作者认为,ICG-99mTc-纳胶体前哨淋巴结活检在早期宫颈癌患者中可行且安全。
- 该杂合示踪剂在所有患者中实现双侧前哨淋巴结检出,检出率高于蓝染剂,可能成为联合技术的替代方案。
研究设计与样本
- 前瞻性先导研究,纳入16例宫颈癌患者。
- 术前19-21小时注射ICG-99mTc-纳胶体,行平面和SPECT/CT淋巴显像。
- 14例患者另行会阴孔周围蓝染剂注射。
- 根据淋巴显像分布及放射性、荧光和/或蓝染信号切除前哨淋巴结,标本行病理学转移分析包括免疫组化。
主要发现
- 淋巴显像和SPECT/CT在所有患者中均显示引流。
- 共切除69枚前哨淋巴结,其中66枚由放射性信号检出,67枚由荧光信号检出。
- 蓝染剂在14例中的12例(85.7%)仅检出35枚前哨淋巴结。
- 所有患者均显示双侧盆腔引流。
- 2例患者诊断为微转移,且为唯一受累淋巴结。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Sentinel lymph node biopsy (SLNB) can be used for nodal staging in early cervical cancer. For this purpose, the tracers most commonly used are radiotracers based on technetium. For the last decade, indocyanine green (ICG) has been used as a tracer for SLNB in other malignancies with excellent results and, more recently, a combination of ICG and a radiotracer has been shown to have the advantages of both tracers. The aim of this study was to evaluate the role of ICG-99mTc-nanocolloid in SLN detection in patients with cervical cancer. METHODS: This prospective study included 16 patients with cervical cancer. The hybrid tracer was injected the day (19-21 h) before surgery for planar and SPECT/CT lymphoscintigraphy. Blue dye was administered periorificially in 14 patients. SLNs were removed according to their distribution on lymphoscintigraphy and when radioactive, fluorescent and/or stained with blue dye. Nodal specimens were pathologically analysed for metastases including by immunochemistry. RESULTS: Lymphoscintigraphy and SPECT/CT showed drainage in all patients. A total of 69 SLNs were removed, of which 66 were detected by their radioactivity signal and 67 by their fluorescence signal. Blue dye identified only 35 SLNs in 12 of the 14 patients (85.7%). All patients showed bilateral pelvic drainage. Micrometastases were diagnosed in two patients, and were the only lymphatic nodes involved. CONCLUSIONS: SLNB with ICG-99mTc-nanocolloid is feasible and safe in patients with early cervical cancer. This hybrid tracer provided bilateral SLN detection in all patients and a higher detection rate than blue dye, so it could become an alternative to the combined technique.
引用
- Paredes P, Vidal-Sicart S, Campos F, et al. Role of ICG-99mTc-nanocolloid for sentinel lymph node detection in cervical cancer: a pilot study. Eur J Nucl Med Mol Imaging. 2017. PMID: 28492965. doi:10.1007/s00259-017-3706-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。